• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质酪氨酸激酶的结构与功能。

Protein tyrosine kinase structure and function.

作者信息

Hubbard S R, Till J H

机构信息

Skirball Institute of Biomolecular Medicine and Department of Pharmacology, New York University School of Medicine, New York, New York 10016, USA.

出版信息

Annu Rev Biochem. 2000;69:373-98. doi: 10.1146/annurev.biochem.69.1.373.

DOI:10.1146/annurev.biochem.69.1.373
PMID:10966463
Abstract

Tyrosine phosphorylation is one of the key covalent modifications that occurs in multicellular organisms as a result of intercellular communication during embryogenesis and maintenance of adult tissues. The enzymes that carry out this modification are the protein tyrosine kinases (PTKs), which catalyze the transfer of the phosphate of ATP to tyrosine residues on protein substrates. Phosphorylation of tyrosine residues modulates enzymatic activity and creates binding sites for the recruitment of downstream signaling proteins. Two classes of PTKs are present in cells: the transmembrane receptor PTKs and the nonreceptor PTKs. Because PTKs are critical components of cellular signaling pathways, their catalytic activity is strictly regulated. Over the past several years, high-resolution structural studies of PTKs have provided a molecular basis for understanding the mechanisms by which receptor and nonreceptor PTKs are regulated. This review will highlight the important results that have emerged from these structural studies.

摘要

酪氨酸磷酸化是多细胞生物中发生的关键共价修饰之一,它是胚胎发育和成年组织维持过程中细胞间通讯的结果。进行这种修饰的酶是蛋白酪氨酸激酶(PTK),它催化将ATP的磷酸基团转移到蛋白质底物上的酪氨酸残基上。酪氨酸残基的磷酸化调节酶活性,并为下游信号蛋白的募集创造结合位点。细胞中存在两类PTK:跨膜受体PTK和非受体PTK。由于PTK是细胞信号通路的关键组成部分,它们的催化活性受到严格调控。在过去几年中,PTK的高分辨率结构研究为理解受体和非受体PTK的调控机制提供了分子基础。本综述将重点介绍这些结构研究中出现的重要结果。

相似文献

1
Protein tyrosine kinase structure and function.蛋白质酪氨酸激酶的结构与功能。
Annu Rev Biochem. 2000;69:373-98. doi: 10.1146/annurev.biochem.69.1.373.
2
Non-receptor protein tyrosine kinases signaling pathways in normal and cancer cells.正常细胞和癌细胞中的非受体酪氨酸蛋白激酶信号通路。
Crit Rev Clin Lab Sci. 2014 Jun;51(3):125-37. doi: 10.3109/10408363.2013.874403. Epub 2014 Jan 22.
3
Redox-linked signal transduction pathways for protein tyrosine kinase activation.用于蛋白酪氨酸激酶激活的氧化还原相关信号转导途径。
Antioxid Redox Signal. 2002 Jun;4(3):517-31. doi: 10.1089/15230860260196326.
4
[Signal transduction by protein tyrosine kinases and antitumor agents].[蛋白酪氨酸激酶介导的信号转导与抗肿瘤药物]
Yao Xue Xue Bao. 2008 Apr;43(4):323-34.
5
Protein tyrosine kinases: autoregulation and small-molecule inhibition.蛋白质酪氨酸激酶:自身调节与小分子抑制
Curr Opin Struct Biol. 2002 Dec;12(6):735-41. doi: 10.1016/s0959-440x(02)00383-4.
6
Ligands and signaling through receptor-type tyrosine phosphatases.配体与通过受体型酪氨酸磷酸酶的信号传导。
IUBMB Life. 2001 Mar;51(3):157-63. doi: 10.1080/152165401753544223.
7
SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.抑制性蛋白酪氨酸激酶Csk与蛋白酪氨酸磷酸酶-HSCF的SH2结构域介导的相互作用
Mol Cell Biol. 2001 Feb;21(4):1077-88. doi: 10.1128/MCB.21.4.1077-1088.2001.
8
Fluorescence-based cloning of a protein tyrosine kinase with a yeast tribrid system.利用酵母三杂交系统基于荧光的蛋白质酪氨酸激酶克隆
Chembiochem. 2005 Aug;6(8):1442-8. doi: 10.1002/cbic.200500047.
9
Analysis of CD28 cytoplasmic tail tyrosine residues as regulators and substrates for the protein tyrosine kinases, EMT and LCK.作为蛋白酪氨酸激酶EMT和LCK的调节因子及底物的CD28胞质尾酪氨酸残基分析
J Immunol. 1997 Jan 15;158(2):580-90.
10
Structural analysis of receptor tyrosine kinases.受体酪氨酸激酶的结构分析
Prog Biophys Mol Biol. 1999;71(3-4):343-58. doi: 10.1016/s0079-6107(98)00047-9.

引用本文的文献

1
The use of intuitive AF-based modelling for the understanding of activation and signalling through insulin-like receptors.使用基于直观房颤的模型来理解通过胰岛素样受体的激活和信号传导。
Front Endocrinol (Lausanne). 2025 Aug 22;16:1633449. doi: 10.3389/fendo.2025.1633449. eCollection 2025.
2
A dynamic scapping workflow for RTK domains: computational modeling of natural products as dual modulators of EGFR and VEGFR signaling in breast cancer.一种用于受体酪氨酸激酶(RTK)结构域的动态筛选工作流程:天然产物作为乳腺癌中表皮生长因子受体(EGFR)和血管内皮生长因子受体(VEGFR)信号传导双重调节剂的计算建模
Mol Divers. 2025 Jul 10. doi: 10.1007/s11030-025-11263-x.
3
Innovative Approaches in Cancer Treatment: Emphasizing the Role of Nanomaterials in Tyrosine Kinase Inhibition.
癌症治疗中的创新方法:强调纳米材料在酪氨酸激酶抑制中的作用。
Pharmaceutics. 2025 Jun 16;17(6):783. doi: 10.3390/pharmaceutics17060783.
4
Plasma proteomic profiling of hospitalized patients co-infected with HIV and SARS-CoV-2.同时感染HIV和SARS-CoV-2的住院患者的血浆蛋白质组学分析
Front Immunol. 2025 Jun 11;16:1601672. doi: 10.3389/fimmu.2025.1601672. eCollection 2025.
5
Advancements in Protein Kinase Inhibitors: From Discovery to Clinical Applications.蛋白激酶抑制剂的进展:从发现到临床应用。
Research (Wash D C). 2025 Jun 21;8:0747. doi: 10.34133/research.0747. eCollection 2025.
6
FGFR3 amplification is predictive of poor prognosis in esophageal squamous cell carcinoma patients.FGFR3基因扩增可预测食管鳞状细胞癌患者的不良预后。
Virchows Arch. 2025 May 26. doi: 10.1007/s00428-024-03884-8.
7
Impact of Tyrosine Kinase Inhibitors on the Expression Pattern of Epigenetic Regulators.酪氨酸激酶抑制剂对表观遗传调控因子表达模式的影响。
Cancers (Basel). 2025 Apr 10;17(8):1282. doi: 10.3390/cancers17081282.
8
Tyrosine phosphorylation of Kir6.2 subunit negatively regulates cardiac K channel activity.Kir6.2亚基的酪氨酸磷酸化对心脏钾通道活性具有负向调节作用。
Basic Res Cardiol. 2025 Apr 19. doi: 10.1007/s00395-025-01108-x.
9
Involvement of the ovarian-specific Mro-IR in oogonia differentiation and oocyte development in freshwater giant prawn .卵巢特异性Mro-IR在淡水大虾卵原细胞分化和卵母细胞发育中的作用
Front Endocrinol (Lausanne). 2025 Apr 3;16:1516849. doi: 10.3389/fendo.2025.1516849. eCollection 2025.
10
Insulin receptor responsiveness governs TGFβ-induced hepatic stellate cell activation: Insulin resistance instigates liver fibrosis.胰岛素受体反应性调控转化生长因子β诱导的肝星状细胞活化:胰岛素抵抗引发肝纤维化。
FASEB J. 2025 Mar 15;39(5):e70427. doi: 10.1096/fj.202402169R.